Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling

2021 ◽  
Vol 321 (4) ◽  
pp. F548-F557
Author(s):  
Kyle H. Moore ◽  
John S. Clemmer

Our physiological model replicates clinical trial results and provides unique insights into possible mechanisms that play a role in glomerular injury and hypertensive kidney disease progression during chronic calcium channel blocker (CCB) therapy. Specifically, these simulations predict the temporal changes in renal function with CCB treatment and demonstrate important roles for tubuloglomerular feedback and efferent arteriolar conductance in the control of chronic kidney disease progression.

Nephrology ◽  
2021 ◽  
Author(s):  
Teerawat Thanachayanont ◽  
Methee Chanpitakkul ◽  
Jukkapong Hengtrakulvenit ◽  
Podjanee Watcharakanon ◽  
Watcharapong Wisansak ◽  
...  

Nephrology ◽  
2019 ◽  
Vol 24 (10) ◽  
pp. 1026-1032 ◽  
Author(s):  
Serena Low ◽  
Xiao Zhang ◽  
Jiexun Wang ◽  
Lee Y Yeoh ◽  
Yan L Liu ◽  
...  

2009 ◽  
Vol 19 (1) ◽  
pp. 33-37 ◽  
Author(s):  
Kamyar Kalantar-Zadeh ◽  
Stephen F. Derose ◽  
Susan Nicholas ◽  
Deborah Benner ◽  
Kumar Sharma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document